Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00050232
Recruitment Status : Completed
First Posted : December 3, 2002
Last Update Posted : July 14, 2016
Information provided by:
Avanir Pharmaceuticals